Copyright
©The Author(s) 2024.
World J Gastroenterol. Feb 14, 2024; 30(6): 556-564
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.556
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.556
Table 3 Cost-effectiveness ratio in the three protocols costs, expressed in Moroccan dirhams
Therapeutic protocol | Overall cost of 100 patients | Effectiveness | Cost-effectiveness ratio |
QT-10 | 58710 | 89.5% | 655 |
QT-14 | 69190 | 94.4% | 732 |
OST-14 | 42710 | 98.1% | 435 |
- Citation: Seddik H, Benass J, Berrag S, Sair A, Berraida R, Boutallaka H. Optimized sequential therapy vs 10- and 14-d concomitant therapy for eradicating Helicobacter pylori: A randomized clinical trial. World J Gastroenterol 2024; 30(6): 556-564
- URL: https://www.wjgnet.com/1007-9327/full/v30/i6/556.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i6.556